#ASCO26: Lilly's plenaries; Incyte's frontline data in lymphoma

June 1, 2026 11:58 AM EDT R&D AS­CO in brief: Lil­ly's ple­nar­ies; In­cyte's front­line da­ta in lym­phoma Lei Lei Wu News Reporter Two ple­nar­ies re­lat­ed to Lil­ly: Re­searchers de­tailed find­ings from an in­ves­ti­ga­tor-spon­sored tri­al us­ing Lil­ly’s CDK4/6 in­hibitor Verzenio in a rare can­cer called ded­if­fer­en­ti­at­ed li­posar­co­ma, show­ing … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER